Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Feasibility of innate allogeneic stem cell transplantation
NL-OMON25484Unknown
- Sponsor
- University Medical Center Utrecht
- Start
- Apr 2015
- Countries
- 1
01
Overview
Open-label, single-arm trial in leukemia and myelodysplastic syndrome (MDS), sponsored by University Medical Center Utrecht. Primary endpoint: Incidence of acute graft-versus-host disease. Status: unknown.
02
Conditions
leukemiamyelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NL-OMON25484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON25484.